PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663455
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663455
Self-administered Drugs Market, By Type, By Indication, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Self-administered Drugs Market size was valued at US$ 88,514.6 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.
Self-administered drugs are those that patients administer to themselves. Both implanted and non-implantable infusion pumps that come into contact with the skin's surface can be used to provide these medications. Self-administered drugs also include over-the-counter, oral, and topical medicines. Patients who lead active lives are looking for medications that will not only save them time but also allow them to stay out of hospitals completely (apart from emergencies). The market for self-administered drugs is expanding as a result of this trend. Policies for reimbursement will also accelerate market expansion. Furthermore, the self-administered drugs market is expected to expand because of factors such as the migration of patient populations to developed nations and the high expense of healthcare, which incentivizes patients to use self-administered drugs.
Self-administered Drugs Market- Market Dynamics
Increase in chronic illnesses
One major reason propelling the self-administered drugs market is the increase in chronic illnesses like diabetes, hypertension, and autoimmune disorders. Drugs that are self-administered are becoming more and more popular as more patients need ongoing medicine. By giving patients the freedom and convenience to take their medications on their schedules, these pharmaceuticals not only lessen the strain on medical institutions but also improve patients' quality of life. Furthermore, individuals are becoming more proactive and knowledgeable about their healthcare due to the cultural shift towards a more health-conscious society, which is raising the demand for and acceptance of self-administered choices.
Self-administered Drugs Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.10% over the forecast period (2025-2032)
Based on type segmentation, the Injectable Drugs category was predicted to show maximum market share in the year 2024
Based on indication segmentation, pain management was the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024
Self-administered Drugs Market- Segmentation Analysis:
The Global Self-administered Drugs Market is segmented on the basis of Type, Indication, and Region.
On the basis of type, the market is segregated into Injectable Drugs, Transdermal Drugs, and Inhaled Drugs. In 2024, the market was dominated by the Injectable Drugs category. With the popularity of biologics and biosimilars, injectable self-administered drugs are becoming more and more popular. These medications frequently need to be administered and dosed precisely, which new developments in auto-injectors and pre-filled syringes have made easier to use at home. Treatments for diseases like rheumatoid arthritis, multiple sclerosis, and different hormonal abnormalities frequently call for injectables, and patients are becoming more and more interested in the ease of self-administration. As more patient-friendly devices and less painful delivery technologies continue to be developed, the injectable market is predicted to increase rapidly.
Based on indication, the market is divided into Diabetes, Cardiovascular, Pain Management, Hormone Replacement, Osteoporosis, and Others. In 2024, the pain management category held a dominant market share. The market for self-administered drugs includes pain management as a crucial application area, demonstrating the rising demand for patient-friendly and efficient ways to treat both acute and chronic pain. Self-administered analgesics, such as topical creams, oral drugs, and transdermal patches, provide substantial benefits in terms of ease and adaptability, enabling patients to modify their course of treatment as necessary. It is anticipated that the need for self-managed pain management choices will increase due to the growing prevalence of diseases, including neuropathic pain and arthritis, which developments will aid in medication formulations and delivery systems.
Self-administered Drugs Market- Geographical Insights
In 2024, North America held a dominant position in the global market for Self-administered Drugs. The rising prevalence of diabetes, cancer, and bone ailments, as well as the strong demand for self-administered drugs among patients coping with these conditions, are the main drivers of the expansion. Additionally, the government of the biggest economies in the region supports the adoption of various self-administered drugs by offering insurance. Increased USFDA medicine approvals pave the way for new market participants to expand. For instance, the USFDA granted additional clearances to Eli Lilly and Company in June 2020 for their novel rapid-acting insulin, "Lyumjev," which is intended to help adults with type 1 and 2 diabetes improve their glycemic control. An innovative version of insulin lispro is called Lyumjev. The business developed a solution to lower A1C levels and quickly absorb insulin into the bloodstream. Additionally, it regulates elevated blood sugar levels in diabetic persons after meals. Without a prescription, this new indication makes the test available to anybody with or without symptoms.
However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The prevalence of chronic illnesses, growing healthcare expenses, and easier access to healthcare services are all contributing to the region's growing need for easy and reasonably priced treatment options. The ageing population has increased attention to chronic condition management, which has fueled the use of self-administered drugs. Additionally, retail pharmacies are being encouraged to expand their online drug distribution due to the healthcare infrastructure investments and the expanding medical tourism industry.
Self-administered Drugs Market- Competitive Landscape:
Among the leading companies in the global market for self-administered drugs are Omnicare, SFK Corporation, Johnson & Johnson, Cardinal Health, McKesson Corporation, and others. By implementing several tactics, including partnerships, collaborations, regional expansion, mergers and acquisitions, and new drug development, to remain competitive in the market, the market's participants are also making a substantial contribution to its growth. Furthermore, to increase patient adherence and develop cutting-edge drug delivery methods, businesses in this sector are making significant investments in research and development. The ongoing release of new goods and technology to meet the changing demands of patients and healthcare professionals intensifies the market's competition. For instance, in September 2021, Abbott Laboratories declared that it had acquired Walk Vascular LLC, a manufacturer of medical devices. By expanding Abbott's peripheral vascular portfolio and advancing endovascular therapeutic solutions, this acquisition will enhance patient care.
Recent Development
February 2024: the FDA has given Novartis permission to introduce Xolair(R) (omalizumab). This self-injectable drug can help prevent anaphylaxis and other allergic responses in adults and children with IgE-mediated food allergies.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SELF-ADMINISTERED DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Omnicare
- SFK Corporation
- Johnson & Johnson
- Cardinal Health
- McKesson Corporation
- Wal-Mart Stores Inc
- Express Scripts Holding Company
- CVS Health
- Walgreens Boots Alliance
- Rite Aid Corporation
- Others
GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Injectable Drugs
- Transdermal Drugs
- Inhaled Drugs
GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
- Diabetes
- Cardiovascular
- Pain Management
- Hormone Replacement
- Osteoporosis
- Others
GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Self-administered Drugs Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Self-administered Drugs Market Snippet by Type
- 2.1.2. Self-administered Drugs Market Snippet by Indication
- 2.1.3. Self-administered Drugs Market Snippet by Country
- 2.1.4. Self-administered Drugs Market Snippet by Region
- 2.2. Competitive Insights
3. Self-administered Drugs Key Market Trends
- 3.1. Self-administered Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Self-administered Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Self-administered Drugs Market Opportunities
- 3.4. Self-administered Drugs Market Future Trends
4. Self-administered Drugs Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Self-administered Drugs Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Self-administered Drugs Market Landscape
- 6.1. Self-administered Drugs Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Self-administered Drugs Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 7.1.2. Injectable Drugs
- 7.1.3. Transdermal Drugs
- 7.1.4. Inhaled Drugs
8. Self-administered Drugs Market - By Indication
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
- 8.1.2. Diabetes
- 8.1.3. Cardiovascular
- 8.1.4. Pain Management
- 8.1.5. Hormone Replacement
- 8.1.6. Osteoporosis
- 8.1.7. Others
9. Self-administered Drugs Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Self-administered Drugs Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Self-administered Drugs Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.7. France
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.7.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.8. Italy
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.9. Spain
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.10. United Kingdom
- 9.3.10.1. Overview
- 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.11. Russia
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.12. Netherlands
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.13. Sweden
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
- 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
- 9.3.15.1. Overview
- 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Self-administered Drugs Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4.8. South Korea
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.8.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4.9. Japan
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Self-administered Drugs Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Self-administered Drugs Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10. Key Vendor Analysis- Self-administered Drugs Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Omnicare
- 10.2.2. SFK Corporation
- 10.2.3. Johnson & Johnson
- 10.2.4. Cardinal Health
- 10.2.5. McKesson Corporation
- 10.2.6. Wal-Mart Stores Inc
- 10.2.7. Express Scripts Holding Company
- 10.2.8. CVS Health
- 10.2.9. Walgreens Boots Alliance
- 10.2.10. Rite Aid Corporation
- 10.2.11. Others
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
